Site Updates
New merkelcell.org website launches! →An overview of Merkel cells, Merkel cell carcinoma, symptoms, and causes.
Learn More →The diagnosis of MCC is made with a skin biopsy, which is examined under the microscope.
Learn More →There are multiple treatments used for MCC, and treatment is generally based on stage of the disease.
Learn More →Disease recurrence and survival are two critical measures of prognosis.
Learn More →Explore resources about Merkel cell carcinoma, including frequently asked questions and our list of verified specialists.
Learn More →June 1, 2019
Journal of the American Academy of Dermatology
June 1, 2019
Paulson K, Nghiem P
Download PDFPublished data for pediatric and young adult patients with Merkel cell carcinoma (MCC) are scarce. Case reports from the United States and Europe suggest that MCC can occur in young persons and may be more aggressive in this setting. We sought to determine the frequency of MCC in pediatric and young adult populations and establish whether MCC is more likely to present at advanced stages in younger people. To minimize referral bias and maximize available data, we used the National Program of Cancer Registries Surveillance Epidemiology and End Results (NPCR SEER) database, which captures incident cancer cases in more than 98% of the US population.
View the clinical publicationThe authoritative source on Merkel cell carcinoma.
Last updated:
June 1, 2019
Created in partnership with:
Seattle Multidisciplinary MCC Team, University of Washington MCC Research, Fred Hutchinson Cancer Research Center, and the Seattle Cancer Care Alliance/Skin Cancer